<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[NOVO — Maj 2022]]></title><description><![CDATA[<p dir="auto">Novo: Koncerndirektør sælger aktier for 9,6 mio. kr. <a href="https://proinvestor.com/investornyt/817087/novo-koncerndirektor-saelger-aktier-for-96-mio-kr" rel="nofollow ugc">https://proinvestor.com/investornyt/817087/novo-koncerndirektor-saelger-aktier-for-96-mio-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400285/novo-maj-2022</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 22:16:49 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400285.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 02 May 2022 13:16:23 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to NOVO — Maj 2022 on Fri, 27 May 2022 11:05:56 GMT]]></title><description><![CDATA[<p dir="auto">Stort fedmemarked <a href="https://borsen.dk/nyheder/virksomheder/biotekboss-forudser-gylden-fremtid-i-fedme?b_source=borsen&amp;b_medium=row_6&amp;b_campaign=news_1" rel="nofollow ugc">https://borsen.dk/nyheder/virksomheder/biotekboss-forudser-gylden-fremtid-i-fedme?b_source=borsen&amp;b_medium=row_6&amp;b_campaign=news_1</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978136</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978136</guid><dc:creator><![CDATA[koden]]></dc:creator><pubDate>Fri, 27 May 2022 11:05:56 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Maj 2022 on Fri, 27 May 2022 05:16:11 GMT]]></title><description><![CDATA[<p dir="auto">Kina og patent udfordringer <a href="https://finans.dk/erhverv/ECE14059913/novo-nordisk-risikerer-yderligere-taesk-paa-kaempemarked-og-staar-foran-stor-patentkloeft/?ctxref=forside" rel="nofollow ugc">https://finans.dk/erhverv/ECE14059913/novo-nordisk-risikerer-yderligere-taesk-paa-kaempemarked-og-staar-foran-stor-patentkloeft/?ctxref=forside</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978137</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978137</guid><dc:creator><![CDATA[koden]]></dc:creator><pubDate>Fri, 27 May 2022 05:16:11 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Maj 2022 on Wed, 25 May 2022 02:44:23 GMT]]></title><description><![CDATA[<p dir="auto">Test</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978130</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978130</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 25 May 2022 02:44:23 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Maj 2022 on Tue, 17 May 2022 12:24:45 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk oplever forsinkelser i produktion af Novorapid</p>
<p dir="auto">Novo Nordisk oplever vanskeligheder med fremstillingen af sin hurtigtvirkende insulin Novorapid 100 E/ml, der nu er en mangelvare, skriver Medwatch med henvisning til Lægemiddelstyrelsen.</p>
<p dir="auto">Årsagen skyldes "forsinkelser hos fremstiller", skriver styrelsen på sin hjemmeside. Hos Paranova, 2care4 og Oriform, der ifølge Medwatch er parallelimportører af midlet, skyldes forsyningsvanskelighederne "kommercielle årsager".</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978133</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978133</guid><dc:creator><![CDATA[Svingtraderen]]></dc:creator><pubDate>Tue, 17 May 2022 12:24:45 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Maj 2022 on Mon, 16 May 2022 07:32:58 GMT]]></title><description><![CDATA[<p dir="auto">Novo-rival får godkendt Ozempic-konkurrent i USA - NY2 <a href="https://proinvestor.com/investornyt/824889/novo-rival-far-godkendt-ozempic-konkurrent-i-usa-ny2" rel="nofollow ugc">https://proinvestor.com/investornyt/824889/novo-rival-far-godkendt-ozempic-konkurrent-i-usa-ny2</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978126</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978126</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 16 May 2022 07:32:58 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Maj 2022 on Wed, 11 May 2022 05:32:21 GMT]]></title><description><![CDATA[<p dir="auto">Køb eller kapitulation? Hvad skal vi forvente af nedturen, og hvorfor sker det lige nu? Er Novo blevet en finansieringsaktie, og hvor blev optimismen af i Bavarian Nordic? Det er nogle af de emner, Hansen og Larsen tager under ærlig behandling i ugens udgave af Investeringspodcasten, hvor der også bliver tid til at besvare et par lytterspørgsmål om sidste uges usædvanlige flash crash. <a href="https://www.proinvestor.com/boards/103415" rel="nofollow ugc">https://www.proinvestor.com/boards/103415</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978134</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978134</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 11 May 2022 05:32:21 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Maj 2022 on Tue, 10 May 2022 09:13:27 GMT]]></title><description><![CDATA[<p dir="auto">Novo indgår forskningssamarbejde med amerikanske biotekselskab <a href="https://proinvestor.com/investornyt/821875/novo-indgar-forskningssamarbejde-med-amerikanske-biotekselskab" rel="nofollow ugc">https://proinvestor.com/investornyt/821875/novo-indgar-forskningssamarbejde-med-amerikanske-biotekselskab</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978135</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978135</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 10 May 2022 09:13:27 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Maj 2022 on Mon, 09 May 2022 04:11:27 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Carnegie: Kursmålet løftes til 1005 kr. fra 906 kr. <a href="https://www.proinvestor.com/investornyt/821014/novo-carnegie-kursmalet-loftes-til-1005-kr-fra-906-kr" rel="nofollow ugc">https://www.proinvestor.com/investornyt/821014/novo-carnegie-kursmalet-loftes-til-1005-kr-fra-906-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978128</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978128</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 09 May 2022 04:11:27 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Maj 2022 on Wed, 04 May 2022 03:01:55 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Deutsche: Kursmål op i 900 kr.<a href="https://www.proinvestor.com/investornyt/818332/novo-deutsche-kursmal-op-i-900-kr" rel="nofollow ugc">https://www.proinvestor.com/investornyt/818332/novo-deutsche-kursmal-op-i-900-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978132</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978132</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 04 May 2022 03:01:55 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Maj 2022 on Tue, 03 May 2022 12:45:01 GMT]]></title><description><![CDATA[<p dir="auto">Novo: Direktører sælger aktier for sammenlagt 23 mio. kr. <a href="https://proinvestor.com/investornyt/817888/novo-direktorer-saelger-aktier-for-sammenlagt-23-mio-kr" rel="nofollow ugc">https://proinvestor.com/investornyt/817888/novo-direktorer-saelger-aktier-for-sammenlagt-23-mio-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978127</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978127</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 03 May 2022 12:45:01 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Maj 2022 on Tue, 03 May 2022 03:39:54 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Citi: Kursmål løftes til 925 kr. fra 800 kr. <a href="https://proinvestor.com/investornyt/817535/novo-citi-kursmal-loftes-til-925-kr-fra-800-kr" rel="nofollow ugc">https://proinvestor.com/investornyt/817535/novo-citi-kursmal-loftes-til-925-kr-fra-800-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978129</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978129</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 03 May 2022 03:39:54 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — Maj 2022 on Mon, 02 May 2022 15:26:04 GMT]]></title><description><![CDATA[<p dir="auto">Aktier: Novo var Nordens mest handlede aktie i april <a href="https://proinvestor.com/investornyt/817151/aktier-novo-var-nordens-mest-handlede-aktie-i-april" rel="nofollow ugc">https://proinvestor.com/investornyt/817151/aktier-novo-var-nordens-mest-handlede-aktie-i-april</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7978131</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7978131</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 02 May 2022 15:26:04 GMT</pubDate></item></channel></rss>